Position
Chief Medical Officer
Company
Flamingo Therapeutics
Description
Flamingo Therapeutics appoints Ezra Cohen, MD, as a new board member with unique expertise in oncology drug development and cancer research, enhancing the company's position in advancing therapeutic options for patients with head and neck cancer.
Quick answer
Flamingo Therapeutics Appoints Ezra Cohen as Chief Medical Officer (March 21, 2024). Flamingo Therapeutics is based in Leuven, Flemish Brabant, Belgium.
- What did Flamingo Therapeutics announce on March 21, 2024?
- Flamingo Therapeutics appoints Ezra Cohen, MD, as a new board member with unique expertise in oncology drug development and cancer research, enhancing the company's position in advancing therapeutic options for patients with head and neck cancer.
- What does Flamingo Therapeutics do?
- Flamingo is pioneering RNA-targeted therapies for oncology with state-of-the art chemistries and a clinical-stage pipeline targeting undruggable transcription factors and splice variants.
- Where is Flamingo Therapeutics based?
- Flamingo Therapeutics is based in Leuven, Flemish Brabant, Belgium.
- Which similar companies made leadership changes around the same time?
- MaaT Pharma (March 21, 2024), BeiGene Ltd (March 20, 2024), Arvinas (March 20, 2024) and BioNTech (March 20, 2024) also announced leadership changes within 45 days of Flamingo Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- MaaT Pharma Appoints Jonathan Chriqui as Chief Business Officer (March 21, 2024)
- BeiGene Appoints Titus Ball as Principal Accounting Officer (March 20, 2024)
- Arvinas Inc. Hires Noah Berkowitz as Chief Medical Officer and Randy Teel as Chief Financial Officer (March 20, 2024)
- BioNTech Appoints Annemarie Hanekamp as Chief Commercial Officer (March 20, 2024)
- FundaMental Pharma Appoints Dr. Lorenz Mayr as Non-Executive Director (March 20, 2024)
- VolitionRx Limited Appoints Dr Andrew Retter as Chief Medical Officer (March 19, 2024)
Who to call at Flamingo Therapeutics, and when
A new leader at Flamingo Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Flamingo Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Flamingo Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Flamingo Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Flamingo Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Flamingo Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.